Patient-reported outcomes (PROs) are increasingly recognized by regulators, clinicians, and patients as valuable tools to collect patient-centered data. This podcast features a panel discussion from the 2025 Chief Medical Officer Summit 360° with biotech CMOs about how to incorporate PROs into clinical trials in ways that improve probabilities of success while avoiding common mistakes. Specifically, the panelists address:
- How PROs provide evidence on the effect of interventions on patient symptoms and quality of life, but by the nature of being subjective, they are prone to bias
- The growth of electronic health technologies provides unprecedented opportunities to systematically collect PROs
- Disadvantages of electronic methods include technical difficulties, cost, longer start-up time, and “digital divide” between patients
To learn more about the Chief Medical Officer Summit 360°, please visit
CMO360.org.
